Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aksu, K.
Right arrow Articles by Doganavsargil, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aksu, K.
Right arrow Articles by Doganavsargil, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 1999; 38: 1279-1281
© 1999 British Society for Rheumatology

Prevalences of hepatitis A, B, C and E viruses in Behçet's disease

K. Aksu, Y. Kabasakal, A. Sayiner1, G. Keser, F. Oksel, A. Bilgiç1, G. Gümüsdis and E. Doganavsargil

Division of Rheumatology, Department of Internal Medicine and
1 Clinical Microbiology, Ege University School of Medicine, Bornova, Izmir, Turkey

Correspondence to: K. Aksu, 80 Sokak No: 27/3, 35040 Bornova, Izmir, Turkey.

Objective. To determine whether Behçet's disease (BD), being a systemic vasculitis of unknown aetiology, is associated with hepatitis viruses (HAV, HBV, HCV and HEV).

Methods. In addition to 124 patients [male:female (M/F): 73/51], all fulfilling the diagnostic criteria of the International Study Group for BD (1991), 14 patients with systemic necrotizing vasculitis (M/F: 7/7), 47 patients with ankylosing spondylitis (M/F: 36/11) and 51 healthy controls (M/F: 22/29) were also included in this study. Serological markers of four different types of hepatitis (anti-HAV IgM, total anti-HAV, HBsAg, anti-HBs, total anti-HBc, anti-HBc IgM, anti-HCV and anti-HEV) were studied in all cases.

Results. There was no difference between the groups with respect to HAV, HCV and HEV serologies. Anti-HBs positivity was observed less frequently in BD compared with healthy controls and systemic vasculitis (P<0.05).

Conclusion. Serological evidence of previous HAV, HCV and HEV infections was not significantly different between Behçet's patients and other groups. However, previous HBV infection was found in a significantly lower number of BD patients as compared with healthy controls and systemic vasculitic patients.

KEY WORDS: Behçet's disease, Hepatitis A virus (HAV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Hepatitis E virus (HEV), Prevalence


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
C. C. Belizna, M. A. Hamidou, H. Levesque, L. Guillevin, and Y. Shoenfeld
Infection and vasculitis
Rheumatology, May 1, 2009; 48(5): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
L.M. Al-Otaibi, S.R. Porter, and T.W.J. Poate
Behcet's Disease: A Review
Journal of Dental Research, March 1, 2005; 84(3): 209 - 222.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.